1-Naphthalenesulfonamide, N-(5-aminopentyl)-5-(dimethylamino)-, 97%, 1g

2-Methyl-2H-[1,2,3]triazol-4-ylamine hydrochloride, 95.0%, 250mg

(2S,3S)-(-)-Bis(diphenylphosphino)butane>93.0%(GC)100mg

1-Cyclohexylpiperazine>98.0%(GC)(T)25g

2-((tert-Butoxycarbonyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylic acid, 97%, 1g

3-Chloro-2,4,5,6-tetrafluoropyridine, 99.0%, 25g

C-(3-Propyl-isoxazol-5-yl)-methylaminehydrochloride, 95.0%, 10g

4-Methyl-5-trifluoromethyl-2H-pyridazin-3-one, 97%, 500mg

Methyl 2,2-dimethyl-3-oxobutanoate, 95.0%, 5g

tert-Butyl 4-(hydroxymethyl)phenylcarbamate, 95.0%, 100g

METHYL 2-(BIS[(TERT-BUTOXY)CARBONYL]AMINO)PROP-2-ENOATE, 95%, 1g

5-Chloropyrimidin-2(1H)-one hydrochloride, 95.0%, 5g

Methylcellulose, powder, 250 g, plastic packaging.